VBIO 8-K 2026-11-02

Valion Bio, Inc. (VBIO) 8-K dated 2026-11-02 — accession 0001683168-26-008221.

Valion Bio, Inc. (VBIO) common stock.

Valion Bio, Inc. filed a 8-K on 2026-11-02. Accession 0001683168-26-008221.

This 8-K covers: Director/officer change (Item 5.02), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VBIO revenue for 2024-12-31 was $780.0K. Net income was -$5.7M. Revenue was down 33.7% from 2023-12-31 to 2024-12-31.

Not investment advice. The VBIO SEC hub lists recent forms. The stock page is the research view.